FratFiles

• Save Paper

The Dangers of Race-Based Medicine
An analysis of new drug therapies specifically targeted towards African American populations with hypertension

I. Introduction to Contemporary Race-Based Therapeutics
On November 11th, 2004, NitroMed, a Massachusetts based pharmaceutical company published a study on the effects of a new drug called BiDil in treating heart failure among African Americans in the New England Journal of Medicine (Taylor 2049). Since announcing the study, NitroMed's research has sparked controversy surrounding the ethical implications and scientific evidence of race-based medicine. This study marks a breakthrough in race-based drug treatments as the first pharmaceutical ever researched, endorsed and targeted for a single ethnic group (Pollack 1). The racially-specific pharmaceutical initiative is a product of tremendous government funding allotted by the Clinton administration to the Human Genome Project at the turn of the millennium. Since then, much medical......

View the rest of this paper...

Approximate Word Count: 4361
Approximate Pages: 18 (250 words per double-spaced page)

Similar Essays

1. The Dangers Of Race Based Medicine
   

   The Dangers of Race Based Medicine The Dangers of Race-Based Medicine An analysis of new drug therapies specifically targeted towards African American populations with

2. Worn Path
   

   times, because of her race, and faced many challenges while growing up. The story is based on an elderly Negro women's journey into town to get medicine for her sick grandson.

3. A Worn Path
   

   Jackson and symbols. While overcoming challenges her character is born. The story is based on an elderly Negro women's journey into town for medicine for her grandson. Along

4. Endless Possibilities In Genetic Engineering
   

   What they don't realize is that we are experimenting with genetics to help out the human race. They don't realize we are not hurting anyone or anything. "If appropriate go-ahead

5. Genetics
   

   have to learn ways to approach the novel problems accompanying this kind of "predictive medicine." Meanwhile exaggerated emphasis on genetic diagnoses draws attention away from